https://medicalxpress.com/ en-us provides the latest news from Sabin Vaccine Institute The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries. This new policy will help ensure access to typhoid vaccination in communities most impacted by the disease, which is responsible for nearly 12 million infections and between 128,000 and 161,000 deaths a year. https://medicalxpress.com/news/2018-04-typhoid-conjugate-vaccine.html Tue, 03 Apr 2018 02:55:13 EDT news441942898 February 27, 2014 – The control and elimination of neglected tropical diseases (NTDs) is one of the most cost-effective ways Indonesia can sustain economic growth and reduce inequality, said scientists today in an analysis published in PLOS Neglected Tropical Diseases. While Indonesia is poised to defeat NTDs by 2020, it has an opportunity to scale up national programs, integrate NTDs with other development efforts, strengthen coordination and enhance collaboration among key partners. https://medicalxpress.com/news/2014-02-indonesia-competitiveness-neglected-diseases-poverty.html Fri, 28 Feb 2014 11:39:31 EST news312809959 New studies revealed today by Latin American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize more infants with new vaccines. The experts called for increased disease monitoring and more surveillance to understand the full extent of pneumococcal disease in the Americas, including its economic impact, and to devise effective strategies to prevent it. https://medicalxpress.com/news/2013-03-potential-shift-burden-pneumococcal-disease.html Tue, 05 Mar 2013 13:00:01 EST news281709953 Today, The Lancet Infectious Diseases published a new report that examines the global economic burden of Chagas disease. In the first study of its kind, researchers measured the health and economic impact of Chagas disease and found that the total economic burden of Chagas disease matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer. https://medicalxpress.com/news/2013-02-highlights-chagas-disease-health-socio-economic.html Thu, 07 Feb 2013 18:30:03 EST news279472375 A recently released report, entitled "Social and Economic Impact Review on Neglected Tropical Diseases," highlights links between neglected tropical diseases (NTDs) and socio-economic prosperity. Published by Hudson Institute's Center for Science in Public Policy, in partnership with the Global Network for Neglected Tropical Diseases, an initiative of the Sabin Vaccine Institute, the paper found NTD control and elimination efforts to be both inexpensive and highly effective, especially when paired with other major disease treatment efforts, making NTD programs one of the most cost-effective public health interventions available. https://medicalxpress.com/news/2013-01-neglected-tropical-disease-global-health.html Thu, 17 Jan 2013 04:15:44 EST news277618537 The Sabin Vaccine Institute (Sabin) today announced the start of Part II of its Phase I clinical trial of the Na-GST-1 vaccine candidate, marking another major milestone in the progress toward developing a human hookworm vaccine. Part II of the trial commenced in Americaninhas, Brazil, following successful vaccinations in Part I of the study, which began in Belo Horizonte, Brazil in late 2011. https://medicalxpress.com/news/2012-11-clinical-trials-first-ever-human-hookworm.html Mon, 05 Nov 2012 12:44:48 EST news271341778 Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million doses packaged in ten-dose vials. The study used data on a vaccine developed by US NIH and the facilities of the Instituto Butantan in Sao Paulo, Brazil. https://medicalxpress.com/news/2012-06-dengue-vaccine-lessened.html Thu, 28 Jun 2012 08:53:53 EDT news260092427 Today, the Sabin Vaccine Institute, in partnership with the George Washington University and the Children's National Medical Center, began vaccinating participants for a Phase 1 clinical trial of a novel human hookworm vaccine. The trial will investigate the Na-GST-1 antigen developed by the Sabin Vaccine Institute Product Development Partnership (Sabin PDP) to prevent hookworm infections in endemic areas. https://medicalxpress.com/news/2012-06-clinical-trial-human-hookworm-vaccine.html Wed, 13 Jun 2012 10:50:25 EDT news258803411 Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities. https://medicalxpress.com/news/2012-05-world-health-endorses-global-access.html Fri, 25 May 2012 11:07:14 EDT news257162814